Underrepresentation of Women in Late-Breaking Cardiovascular Clinical Trials
Journal of Women's Health · 2023
DOI: 10.1089/jwh.2022.0536 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Women's Health, 2023. Verfasst von Jessica N Holtzman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Cardiology, Heart Failure. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Cardiovascular disease is the leading cause of mortality for women and men. Prior studies have demonstrated the underrepresentation of women in published clinical trials, but no study to date has assessed inclusion of women in late-breaking clinical trials (LBCTs) presented at national meetings. The objective is to characterize the inclusion of women participants in LBCT presented at the 2021 American College of Cardiology (ACC), American Heart Association (AHA), and European Society of Cardiology (ESC) annual meetings and identify trial characteristics associated with improved inclusion.
Methods
LBCT presented at the 2021 ACC, AHA, and ESC meetings were identified and the inclusion of women as participants was assessed. The inclusion to prevalence ratio (IPR) was calculated by dividing the percentage of women participants by the percentage of women in the disease population. IPRs
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
- Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Medicine, Hackensack Meridian Health Palisades Medical Center, Edison, New Jersey, USA.
- Department of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA.
- Clinical Cardiology Section, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID-Profile: Jessica N Holtzman
Zitieren
APA
Holtzman, J. N., Kaur, G., Power, J. E., Barkhordarian, M., Mares, A., Goyal, A., & Gulati, M. (2023). Underrepresentation of Women in Late-Breaking Cardiovascular Clinical Trials. Journal of Women's Health. https://doi.org/10.1089/jwh.2022.0536
Vancouver
Holtzman JN, Kaur G, Power JE, Barkhordarian M, Mares A, Goyal A, et al. Underrepresentation of Women in Late-Breaking Cardiovascular Clinical Trials. Journal of Women's Health. 2023. doi:10.1089/jwh.2022.0536
BibTeX
@article{Holtzman2023,
author = {Holtzman, Jessica N and Kaur, Gurleen and Power, Juliette E and Barkhordarian, Maryam and Mares, Adriana and Goyal, Amit and Gulati, Martha},
title = {Underrepresentation of Women in Late-Breaking Cardiovascular Clinical Trials},
journal = {Journal of Women's Health},
year = {2023},
doi = {10.1089/jwh.2022.0536}
}
EUVIMED